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 21 year(s), femalePatient:
Clinical History
A 21-year-old female presented at the emergency department with drooping of the left eyelid and
left mouth corner. Neurological examination showed a left lower motor neuron facial nerve palsy.
Otoscopy showed narrowing of the left external auditory canal.
Imaging Findings
Magnetic resonance imaging (MRI) demonstrated a space-occupying lesion in the mastoid portion
of the left temporal bone. On T1-weighted imaging (T1-WI), the lesion was of low signal intensity
(SI) (Fig. 1A). On T2-weighted imaging (T2-WI), the lesion displayed heterogeneous intermediate
to high SI (Fig. 1B). Diffusion-weighted images and apparent diffusion coefficient maps showed no
significant diffusion restriction (Fig. 2). After intravenous administration of gadolinium-based
contrast medium, the lesion enhanced heterogeneously, with marked enhancement in the areas
which were of intermediate SI on T2-WI, and absence of enhancement in the areas which were of
high SI on T2-WI (Fig. 3)
Cone-beam computed tomography confirmed the presence of a destructive osteolytic
space-occupying lesion in the left mastoid (Fig. 4). The lesion eroded the facial canal, explaining
the facial nerve palsy of the patient. The lesion also extended into the external auditory canal,
explaining narrowing of this canal on otoscopy.
Discussion
CMF is an uncommon benign bone tumor of cartilaginous origin (1, 2, 3). It is usually found in the
metaphyses of the long bones of the lower extremities, especially the proximal metaphysis of the
tibia (4). CMF is also seen in the flat bones and bones of hands and feet. There is a slight
predilection in males and a peak incidence in the second and third decades. CMF is rarely
encountered in the skull base and is extremely rare in the mastoid portion of the temporal bone (5,
6). This case is only the eleventh identified in the literature (Table 1).
Clinical perspective: Patients with CMF of the appendicular skeleton primarily complain of pain
and soft tissue swelling. Symptoms of CMF of the mastoid include hearing loss (7-11), facial nerve
palsy (4, 5, 12), otalgia (2, 4, 9), and vertigo (6, 8).
On plain radiographs, CMF of the appendicular skeleton is often seen as an eccentric radiolucent
lesion with a well-defined sclerotic margin (13). On MRI, CMF of the appendicular skeleton shows
low SI on T1-WI and high SI on T2-WI. After intravenous administration of gadolinium-based
contrast medium, peripheral nodular enhancement is seen in 70 % of lesions, while diffuse contrast
enhancement is seen in 30% (14). For CMF of the mastoid, (cone-beam) CT and MRI are helpful in
elucidating bone and soft tissue extension, respectively. On (cone-beam) CT, CMF of the mastoid is
seen as a destructive, osteolytic, space-occupying lesion. Intratumoral calcifications are more
frequently seen in CMF of the mastoid compared to CMF of the appendicular skeleton. On MRI,
CMF of the mastoid shows low SI on T1-WI and heterogeneous intermediate to high SI on T2-WI.
This heterogeneity can be attributed to the varying composition of chondroid, myxoid, and fibrous
elements. Sometimes, cystic or hemorrhagic foci are seen. After intravenous administration of
gadolinium-based contrast medium, there is heterogeneous enhancement, with clear enhancement in
the areas which show intermediate SI on T2-WI, and absence of enhancement in the areas which
show high SI on T2-WI. The latter are probably composed of predominantly chondroid tissue.
Compared to CMF of the appendicular skeleton, CMF of the mastoid can occur at an older age,
contains more intratumoral calcifications and shows more heterogeneous SI on T2-WI. Since both
radiological and histopathological findings often show considerable overlap with other diseases,
including endolymphatic sac tumors and malignant cartilaginous tumors, the diagnosis of CMF
remains challenging.
Final Diagnosis
Chondromyxoid fibroma of the mastoid
Differential Diagnosis List
Endolymphatic sac tumor, Chondroma and chondrosarcoma, Facial nerve schwannoma
Figures
Figure 1 Axial T1-WI (A) and T2-WI (B)
Axial T1-weighted image (T1-WI) shows a space-occupying lesion of low signal intensity
(SI) in the mastoid (asterisk). 
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Axial T2-weighted image (T2-WI) shows a space-occupying lesion of heterogeneous
intermediate to high SI in the mastoid (asterisk). 
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Figure 2 Axial DWI (A) and ADC maps (B)
Axial diffusion weighted image (DWI) shows no significant diffusion restriction (asterisk). 
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Axial apparent diffusion coefficient (ADC) map shows no significant diffusion restriction
(asterisk) 
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Figure 3 Axial T1-WI after intravenous administration of gadolinium-based contrast medium
On axial T1-WI after intravenous administration of gadolinium-based contrast medium, the
lesion shows clear enhancement (asterisk), with exception of the anterior part, which does
not enhance (arrow). 
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Figure 4 Axial cone-beam computed tomography of the left mastoid
Axial cone-beam computed tomography confirms the destructive osteolytic space-occupying
lesion in the left mastoid (asterisk), with erosion of the facial canal (arrow) 
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Axial cone-beam computed tomography confirms the destructive osteolytic space-occupying
lesion in the left mastoid (asterisk), with erosion of the posterior wall of the external acoustic
meatus (arrow). 
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Figure 5 Overview of all published cases of CMF of the mastoid
Overview of all published cases of chondromyxoid fibroma (CMF) in the mastoid 
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